According to the latest press release, dated September 13, 2023, Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a developer and partner in various cutting-edge diagnostic and medical device technologies, has entered into a distribution partnership with Hero LifeCare, a significant player in the healthcare and emergency device industry. Hero LifeCare, along with its subsidiary Rapid Oxygen, is known for manufacturing and marketing innovative healthcare and emergency response products, including the FDA-cleared R15 first-aid emergency oxygen device, which was developed in collaboration with the University of Michigan.

Hero LifeCare sees the potential for sales growth with Therma Bright’s Venowave device, which offers opportunities similar to those presented by the R15. The partnership is significant because Hero LifeCare has strong connections with large medical and healthcare practices, as well as an e-commerce platform at, which provides direct-to-consumer opportunities. This partnership reflects Hero LifeCare’s commitment to offering innovative health technology solutions to its clients to expand its product offerings and overall growth.

Initially, Hero LifeCare will utilize the temporary CMS CPT® and HCPCS codes that are already being used by other U.S. distribution partners, pending approval of permanent codes by CMS (Centers for Medicare & Medicaid Services).

Therma Bright Inc. anticipates providing further updates as it expands its distribution network for the Venowave device, including updates on the permanent CPT® and HCPCS codes.

About Hero LifeCare:

Hero LifeCare focuses on the development and marketing of technologically advanced products, devices, and software to enhance emergency response, safety, and healthcare. The company manufactures and distributes innovative healthcare and emergency response products through its direct salesforce and online platform Hero’s subsidiary, Rapid Oxygen Company, produces the R15, a first-aid oxygen generator designed for use in schools, airports, workplaces, convention centers, government buildings, and homes. The device does not require a prescription and can be used by anyone, anywhere. Hero is also working on the Smart Hero Station, intended to enhance public safety and provide a smart response to emergencies.

About Therma Bright Inc.:

Therma Bright is involved in the development and partnership of a wide range of advanced, proprietary diagnostic and medical device technologies. Their focus is on delivering innovative solutions to consumers and medical professionals to address critical medical and healthcare challenges. Therma Bright Inc. is publicly traded on the (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX).

For more information, you can visit their website at

This news release contains forward-looking statements related to future events, particularly the commercialization and sales of the Venowave and related technology. These forward-looking statements involve known and unknown risks, uncertainties, and factors that may cause actual results to differ from those expressed or implied by these statements. They should not be interpreted as guarantees of future performance or results. Actual results may vary due to several factors and risks. While the forward-looking statements are based on what the Company’s management believes are reasonable assumptions, the Company cannot guarantee that actual results will align with these statements. These forward-looking statements are made as of the date of the news release, and the Company disclaims any intention or obligation to update or revise them unless required by applicable securities regulations. The TSX Venture Exchange and its Regulation Services Provider do not accept responsibility for the adequacy or accuracy of this press release.

For more insights and analysis, visit


Share :

Latest News